The purpose of the activities carried out under this Regulation shall be to:
(a) (a) optimise the impact of existing interventions, services and commodities aimed at preventing and fighting the major communicable diseases affecting the poorest populations;
(b) (b) increase the affordability of key pharmaceuticals and diagnostics for the three diseases;
(c) (c) increase research and development, including vaccines, microbicides and innovative treatments.